Oklo is a development-stage advanced nuclear company. Its core plan is to deploy small fast-fission power plants under the Aurora Powerhouse brand, build related nuclear fuel recycling and fabrication capabilities, and develop domestic radioisotope production. The company reports one operating segment, so investors should view the business as an integrated advanced nuclear platform rather than a set of separately reported divisions.
Oklo is not yet earning power revenue from an operating Aurora plant. In Q2 2026, the company reported $1.210 million of revenue, compared with no revenue in Q2 2025. Most of that revenue came from acquired engineering and manufacturing subsidiaries, with $0.800 million from engineering and consulting services, $0.168 million from manufacturing and fabrication services, and $0.242 million from other revenue.
The intended business model has three main layers
- Aurora powerhouses: Oklo aims to own or deploy fast-fission power plants that provide firm clean electricity. This model differs from selling only reactor equipment, since future economics are tied to project deployment, licensing, fuel supply, and long-term power demand.
- Fuel-cycle integration: The company is developing recycling and fabrication capabilities designed to convert used nuclear fuel and other nuclear materials into usable reactor fuel. This is strategically important because fuel availability is a major bottleneck for advanced reactors.
- Radioisotopes and specialized engineering: Oklo is building a radioisotope business for medical, industrial, space, defense, research, and national-security uses. Its June 2026 acquisitions of ARMEC and Creative Engineers added precision manufacturing, prototyping, mechanical engineering, and sodium and alkali-metal process capabilities that also serve government and commercial customers.
Oklo’s market position is early but differentiated. It operates in the advanced nuclear and small modular reactor ecosystem, yet it has no commercial Aurora power plant in service. Its value proposition rests on faster, smaller, fuel-flexible reactor deployment paired with a more vertically integrated fuel and manufacturing strategy.
The company’s competitive advantages include several first-mover claims and strategic assets
- Regulatory positioning: Oklo highlights the first Department of Energy site-use permit for a commercial advanced fission plant and the first custom combined license application for an advanced reactor submitted to the U.S. Nuclear Regulatory Commission.
- U.S. project footprint: The company identifies deployment activity in Alaska, Idaho, Ohio, Tennessee, and Texas, keeping its disclosed commercial and regulatory pathway heavily U.S.-focused.
- Vertical integration: Oklo is developing reactor deployment, fuel recycling, fuel fabrication, isotope production, and specialized manufacturing capabilities within one platform.
- Balance sheet support: As of June 30, 2026, Oklo held $3.006 billion of cash, cash equivalents, and marketable debt securities, giving it substantial funding for development work relative to many early-stage nuclear peers.
- Adjacent isotope progress: The Groves Isotope Test Reactor in Texas reached first criticality in August 2026, and Groves-2 Forge was selected in October 2026 under the DOE and NRIC Nuclear Energy Launch Pad initiative, with an initial focus on lutetium-177.
Oklo’s direct competitors include other advanced nuclear and small modular reactor developers, established reactor vendors, nuclear utilities, and companies pursuing alternative firm clean power technologies. A useful U.S.-listed comparison is NuScale Power, another public advanced nuclear developer. NuScale’s technology and commercialization approach differ from Oklo’s fast-reactor and fuel-cycle model, but both companies compete for investor capital, utility and industrial customer attention, government support, and regulatory credibility in the emerging small reactor market.
Oklo remains pre-commercial for its central Aurora power business. The company’s Q2 2026 net loss was $48.536 million, and first-half 2026 net cash used in operating activities was $65.459 million. Its current market position therefore depends less on present revenue scale and more on whether it converts technical, licensing, fuel, isotope, and project-development milestones into operating assets and long-term contracted demand.